Have we realized the full potential of β-lactams for treating drug-resistant TB?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Have we realized the full potential of β-lactams for treating drug-resistant TB?

Published:2018-06-22 Issue:9 Volume:70 Page:881-888
ISSN:1521-6543
Container-title:IUBMB Life
language:en
Short-container-title:IUBMB Life

Author:

Story-Roller Elizabeth¹,Lamichhane Gyanu¹^ORCID

Affiliation:

1. Center for Tuberculosis Research Division of Infectious Diseases, Department of Medicine; Johns Hopkins University; Baltimore MD USA

Funder

NIH

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Genetics,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/iub.1875/fullpdf

Reference81 articles.

1. The antibiotics market;Hamad;Nat. Rev. Drug Discov.,2010

2. β-lactam antibiotics and mycobacteria;Finch;J. Antimicrob. Chemother.,1986

3. Crystal structure and activity studies of the Mycobacterium tuberculosis β-lactamase reveal its critical role in resistance to β-lactam antibiotics;Wang;Antimicrob. Agents Chemother.,2006

4. Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis;Hugonnet;Science (New York, N.Y),2009

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of Mycobacterium tuberculosis;Antimicrobial Agents and Chemotherapy;2024-04-03

2. Ethambutol and Meropenem/Clavulanate Synergy Promotes Enhanced Extracellular and Intracellular Killing ofMycobacterium tuberculosis;2023-10-26

3. In vitro activity of new combinations of β-lactam and β-lactamase inhibitors against the Mycobacterium tuberculosis complex;Microbiology Spectrum;2023-10-17

4. Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis;Microbiology Spectrum;2023-08-17

5. The In vitro activity of carbapenems alone and in combination with β-lactamase inhibitors against difficult-to-treat mycobacteria; Mycobacterium tuberculosis, Mycobacterium abscessus, and Mycobacterium avium complex: A systematic review;INT J MYCOBACT;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3